Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Isonics Corporation Files Form 10-QSB for Second Quarter of Fiscal 2005; Company Notes Improved Balance Sheet and Reaffirms Commitment to Growth through Recent Initiatives in Homeland Security, Advanced Silicon Wafer Technology and Life Sciences
- GOLDEN, Colo. -- Isonics Corporation (Nasdaq:ISON), committed to the development of next-generation technology for the homeland security and semiconductor markets, on Wednesday reported revenues and financial results for the second quarter ended October 31, 2004. The Company reported revenues of $3,065,000 for the three months ended October 31, 2004, as...
- Research articles 2004-12-17
- European specialty players revamp and replace their strategy. (Focus 2003: Specialty Chemicals/ChemSpec Europe Preview).
- Threatened with commoditization, companies take drastic measures, not only cutting costs and divesting operations, but also seeking an entirely different, closer relationship with their customers. Under pressure from sluggish demand, difficult Threatened with commoditization, companies take drastic measures, ...
- Research articles 2003-04-28
- Michigan has the potential to become a biotech powerhouse, but for a state built on manufacturing, the task of developing that potential has been described as "Like playing chess with no squares": Part 1 of 2.
- Byline: Andrew Dietderich When entrepreneurs and scientists working in life sciences step off the plane in Detroit, Randal Charlton said they should be greeted by a large welcoming party. For starters, the chairman of Ann Arbor-based MichBio sai Byline: Andrew Dietderich...
- Research articles 2006-06-05
- Axcan Pharma to Present at the UBS Global Life Sciences Conference.(Conference news)
- MONT-SAINT-HILAIRE, QUEBEC, Sep 19, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, September 26, 2007, President and Chief Executive Officer, MONT-SAINT-HILAIRE, QUEBEC, Sep 19, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the...
- Research articles 2007-09-19
- PRAECIS PHARMACEUTICALS INCORPORATED Provides Company Update at the 2004 UBS Global Life Sciences Conference
- WALTHAM, Mass. -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today presented a Company update at the 2004 UBS Global Life Sciences Conference in New York. Malcolm L. Gefter, Ph.D., Chairman and Chief Executive Officer of PRAECIS, and Edward C. English, PRAECIS' recently appointed Vice President, Chief Financial Officer and Treasurer, provided...
- Research articles 2004-09-29
- Life Sciences Sector Offers Investors Growth, But at a Price.(Brief Article)
- Impressive growth rates tempered by high valuations. INVESTORS SEEKING higher growth opportunities in the chemical-based arena may want to take a closer look at the emerging life sciences industry, where companies are applying chemistry to dev Impressive growth rates...
- Research articles 2000-11-27
- CytRx to Present Initial ALS Trial Data at the UBS Global Life Sciences Conference; Live Webcast Scheduled September 26 at 9:30 a.m. ET
- LOS ANGELES -- CytRx Corporation (Nasdaq:CYTR) today announced that initial findings from data analysis of the Company's Phase IIa clinical trial with arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) will be presented by President and CEO Steven A. Kriegsman and Senior Vice President of...
- Research articles 2006-09-20
- Major biotechs weather storm in 2002. (Markets: Life Sciences).(Industry Overview)
- FOR THE MAJOR US biotechnology companies, analysts see 2002 as a transition to improved earnings in 2003, with several companies seeking to move beyond capacity shortfalls, inventory overhang or lackluster clinical trial results and product delays. FOR THE MAJOR US biotechnology companies, analysts see...
- Research articles 2002-12-02
- BASF May Favor Life Sciences At the Expense of Pharmaceuticals.
- The company is concerned about drug sales in the US. BASF HINTED last week that it may dispose of part or all of its pharmaceutical business to strengthen its position in another life sciences sector, such as crop protection. ...
- Research articles 1999-11-15
- DJO Incorporated to Present at the UBS Global Life Sciences Conference on September 26, 2006; Live Webcast Provided
- SAN DIEGO -- DJO Incorporated (NYSE:DJO), a global provider of products and services that promote musculoskeletal and vascular health, today announced that the Company has been invited to make a presentation at the UBS Global Life Sciences Conference, held at the Grand Hyatt New York. The Company's presentation will focus...
- Research articles 2006-09-19
- AHP and Monsanto Merge to Form Colossal Life Science Firm.
- New company will dominate ag chemicals and biotech. AMERICAN HOME Products Corporation and Monsanto Company arc planning to merge in a $33 billion tax-free stock swap, creating the world's largest life sciences company with 75,000 employees and $2 New company will dominate ag...
- Research articles 1998-06-08
- Ex-state official now Deloitte & Touche agent.(Brief Article)
- LANSING - For nearly 14 years, Al Aceves was in state government, working with companies on economic-development projects and potential state aid. Now, he's on the opposite side of the negotiating table. Aceves, a former deputy director and account LANSING - For nearly 14...
- Research articles 2000-04-17
- Motorola shedding biochip biz; Galvin's 'next big thing' on the block, a casualty of cost-cutting.(Christopher Galvin's biochip dreams with Motorola shattered as it sells Life Sciences business)(Brief Article)(Statistical Data Included)
- Motorola Inc. has put its life sciences business up for sale in a move that is dashing CEO Christopher Galvin's dream of making biochips the company's next big success. The fledgling unit-which has an estimated 400 workers in Northbrook; Tempe, Ar Motorola Inc....
- Research articles 2002-05-13
Additional Resources
- Hercules Technology Anticipates Approximately $7.0 Million of Liquidity From Two M&A Exit Events Within its Life Science Portfolio
- ~ Significant FDA or clinical milestones achieved by four portfolio companies within its Life Science portfolio ~ PALO ALTO, Calif. -- Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), the leading specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science...
- Research articles 2009-02-10
- Burrill & Company - A Life Sciences Merchant Bank
- This paper focuses on Biotech industry.Burrill & Company is a life sciences merchant bank, focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, human healthcare and related medical technologies, wellness and nutraceuticals, agricultural technologies, and industrial biotechnology. Burrill & Company assists life science companies in identifying, negotiating and closing strategic...
- White papers 2004-06-09
- entimo AG Chooses IBM as Preferred Technology Partner to Help Deliver On Demand Business Solutions to Meet Healthcare and Life Sciences Industry Customer Needs
- entimo AG, a leading company providing manufacturers of the pharmaceutical and crop science industries with high quality e-business Research & Development (eR&D) products and solutions, as well as custom IT solutions for the regulatory authorities, today announced it has achieved industry optimized in IBM's PartnerWorld Industry Networks for healthcare and...
- Research articles 2005-09-29
- ERP Issues for the Mid-Sized Life Science Company With an Analysis of Microsoft Business Solutions-Great Plains and Merit Solutions
- The mid-sized life science company has most of the same business requirements and all the regulatory issues of a large life science company. However, the mid-sized life science company has fewer resources at its disposal to address these issues. While most Enterprise Resource Planning ERP companies have made their name...
- White papers 2004-06-01
- Swedish contract manufacturer PartnerTech AB signs new production agreement with life science research company Biotage AB
- NORDIC BUSINESS REPORT-29 May 2008-Swedish contract manufacturer PartnerTech AB signs new production agreement with life science research company Biotage ABC1994-2008 M2 COMMUNICATIONS LTD http://www.m2.com Swedish contract development and manufacturing company PartnerTech AB (OMX Stockholm: PART) said on Thursday (29 May) that it has signed a new instruments manufacturing agreement...
- Research articles 2008-05-29
- Life Science Gems: GBLSE, BLSI, CHAI, LSRI, CALP.
- M2 PRESSWIRE-28 April 2004-InvestSource Inc.: Life Science Gems: GBLSE, BLSI, CHAI, LSRI, CALPC1994-2004 M2 COMMUNICATIONS LTD RDATE:04282004 Global Life Sciences Incorporated (OTCBB: GBLSE) held strong during yesterday`s trading session; Keep a green alert on this company as new innovations and trends...
- Research articles 2004-04-28
- Swedish life science research company Biotage AB to close production plant in Virginia
- NORDIC BUSINESS REPORT-23 January 2009-Swedish life science research company Biotage AB to close production plant in VirginiaC1994-2009 M2 COMMUNICATIONS LTD http://www.m2.com Swedish life science research company Biotage AB (OMX Stockholm:BIOT) said on Thursday (22 January) that it has decided to outsource all of its instrument production to contract manufacturers...
- Research articles 2009-01-23
- << Previous
- page 1 of 1
- Next >>
